Related Experiment Video
Updated: May 20, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Tight disease control in early RA
Deepali Sen1, Richard Brasington
1Division of Rheumatology, Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA. dsen@dom.wustl.edu
Abstract:
The past decade has brought increasing evidence to support aggressive therapeutic intervention in early rheumatoid arthritis (RA). Treat-to-target strategies that focus on frequent monitoring and treatment adjustments to achieve states of low disease activity or clinical remission have shown superior long-term results. Both oral disease-modifying antirheumatic drugs and biologic agents are effective in treating early RA. It remains unclear if initial combination therapy or biologic use is more effective in early active disease as compared with the traditional approach. The authors review various studies on the treatment of early RA with a focus on studies with a treat-to-target approach.
Insights
Aggressive treatment for early rheumatoid arthritis (RA) using treat-to-target strategies improves long-term outcomes. This review examines studies on early RA management, including oral and biologic therapies, focusing on achieving remission.
Area of Science:
- Rheumatology
- Clinical Medicine
- Pharmacology
Background:
- Growing evidence supports aggressive intervention for early rheumatoid arthritis (RA).
- Treat-to-target strategies in RA management yield superior long-term results.
- Both oral disease-modifying antirheumatic drugs (DMARDs) and biologic agents are effective for early RA.
Purpose of the Study:
- To review studies on early rheumatoid arthritis treatment.
- To focus on the treat-to-target approach in managing early RA.
- To evaluate the effectiveness of different therapeutic strategies in early active RA.
Main Methods:
- Literature review of studies on early rheumatoid arthritis treatment.
- Analysis of research employing treat-to-target strategies.
- Comparison of various therapeutic interventions, including oral DMARDs and biologics.
Main Results:
- Treat-to-target strategies demonstrate superior long-term outcomes in early RA.
- Oral DMARDs and biologic agents show efficacy in treating early RA.
- Ongoing research is needed to clarify optimal initial therapy for early active RA.
Conclusions:
- Aggressive therapeutic intervention is beneficial for early rheumatoid arthritis.
- Treat-to-target strategies are effective for achieving low disease activity or remission in RA.
- Further research is required to determine the most effective initial treatment for early active RA.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
